Henrietta Lacks Enhancing Cancer Research Act of 2019 became law 649 days after introduction, with cosponsors from both parties
IntroducedMar 28, 2019
Reported—
Passed one chamberDec 9, 2020
Passed bothDec 18, 2020
LawJan 5, 2021
What it changes · CRS summary
Written by the Congressional Research Service [2]. 44 words.
Henrietta Lacks Enhancing Cancer Research Act of 2019 This bill requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.
Context
- Committees
- House Armed Services Committee
House Energy and Commerce Committee
House Veterans' Affairs Committee
Senate Health, Education, Labor, and Pensions Committee - Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 5 of 85 bills enacted since 2013
- Text versions
- 5, from enrolled bill to public law · 778 words
- Subjects
- CancerCongressional oversightDrug safety, medical device, and laboratory regulationGovernment studies and investigationsMedical researchMinority health +1 more
- Latest action
- Jan 5, 2021: Became Public Law No: 116-291.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 2
Each bill appears once, under its strongest link. 2 in all.
Identical or companion · 1
- 116th S. 946 Henrietta Lacks Enhancing Cancer Research Act of 2019 D · Introduced
Related, per CRS or House · 1
- 116th H.R. 6637 Health Equity and Accountability Act of 2020 D · Introduced
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]